These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 24162158)

  • 1. Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypes.
    Prat A; Karginova O; Parker JS; Fan C; He X; Bixby L; Harrell JC; Roman E; Adamo B; Troester M; Perou CM
    Breast Cancer Res Treat; 2013 Nov; 142(2):237-55. PubMed ID: 24162158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer.
    Prat A; Parker JS; Karginova O; Fan C; Livasy C; Herschkowitz JI; He X; Perou CM
    Breast Cancer Res; 2010; 12(5):R68. PubMed ID: 20813035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelial and mesenchymal subpopulations within normal basal breast cell lines exhibit distinct stem cell/progenitor properties.
    Sarrio D; Franklin CK; Mackay A; Reis-Filho JS; Isacke CM
    Stem Cells; 2012 Feb; 30(2):292-303. PubMed ID: 22102611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor initiating but differentiated luminal-like breast cancer cells are highly invasive in the absence of basal-like activity.
    Kim J; Villadsen R; Sørlie T; Fogh L; Grønlund SZ; Fridriksdottir AJ; Kuhn I; Rank F; Wielenga VT; Solvang H; Edwards PA; Børresen-Dale AL; Rønnov-Jessen L; Bissell MJ; Petersen OW
    Proc Natl Acad Sci U S A; 2012 Apr; 109(16):6124-9. PubMed ID: 22454501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STAT1-deficient mice spontaneously develop estrogen receptor α-positive luminal mammary carcinomas.
    Chan SR; Vermi W; Luo J; Lucini L; Rickert C; Fowler AM; Lonardi S; Arthur C; Young LJ; Levy DE; Welch MJ; Cardiff RD; Schreiber RD
    Breast Cancer Res; 2012 Jan; 14(1):R16. PubMed ID: 22264274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normal Breast-Derived Epithelial Cells with Luminal and Intrinsic Subtype-Enriched Gene Expression Document Interindividual Differences in Their Differentiation Cascade.
    Kumar B; Prasad M; Bhat-Nakshatri P; Anjanappa M; Kalra M; Marino N; Storniolo AM; Rao X; Liu S; Wan J; Liu Y; Nakshatri H
    Cancer Res; 2018 Sep; 78(17):5107-5123. PubMed ID: 29997232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted Pten deletion plus p53-R270H mutation in mouse mammary epithelium induces aggressive claudin-low and basal-like breast cancer.
    Wang S; Liu JC; Kim D; Datti A; Zacksenhaus E
    Breast Cancer Res; 2016 Jan; 18(1):9. PubMed ID: 26781438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TOX3 is expressed in mammary ER(+) epithelial cells and regulates ER target genes in luminal breast cancer.
    Seksenyan A; Kadavallore A; Walts AE; de la Torre B; Berel D; Strom SP; Aliahmad P; Funari VA; Kaye J
    BMC Cancer; 2015 Jan; 15():22. PubMed ID: 25632947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterizing the HER2/neu status and metastatic potential of breast cancer stem/progenitor cells.
    Pommier SJ; Quan GG; Christante D; Muller P; Newell AE; Olson SB; Diggs B; Muldoon L; Neuwelt E; Pommier RF
    Ann Surg Oncol; 2010 Feb; 17(2):613-23. PubMed ID: 19838757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of cellular and genetic drivers of breast cancer heterogeneity in genetically engineered mouse tumour models.
    Melchor L; Molyneux G; Mackay A; Magnay FA; Atienza M; Kendrick H; Nava-Rodrigues D; López-García MÁ; Milanezi F; Greenow K; Robertson D; Palacios J; Reis-Filho JS; Smalley MJ
    J Pathol; 2014 Jun; 233(2):124-37. PubMed ID: 24615332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic and functional characterisation of the luminal cell hierarchy of the mammary gland.
    Shehata M; Teschendorff A; Sharp G; Novcic N; Russell IA; Avril S; Prater M; Eirew P; Caldas C; Watson CJ; Stingl J
    Breast Cancer Res; 2012 Oct; 14(5):R134. PubMed ID: 23088371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional heterogeneity within the CD44 high human breast cancer stem cell-like compartment reveals a gene signature predictive of distant metastasis.
    Leth-Larsen R; Terp MG; Christensen AG; Elias D; Kühlwein T; Jensen ON; Petersen OW; Ditzel HJ
    Mol Med; 2012 Sep; 18(1):1109-21. PubMed ID: 22692575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Claudin-low breast cancers: clinical, pathological, molecular and prognostic characterization.
    Sabatier R; Finetti P; Guille A; Adelaide J; Chaffanet M; Viens P; Birnbaum D; Bertucci F
    Mol Cancer; 2014 Oct; 13():228. PubMed ID: 25277734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transgenic IGF-IR overexpression induces mammary tumors with basal-like characteristics, whereas IGF-IR-independent mammary tumors express a claudin-low gene signature.
    Franks SE; Campbell CI; Barnett EF; Siwicky MD; Livingstone J; Cory S; Moorehead RA
    Oncogene; 2012 Jul; 31(27):3298-309. PubMed ID: 22020329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cells.
    Herschkowitz JI; Zhao W; Zhang M; Usary J; Murrow G; Edwards D; Knezevic J; Greene SB; Darr D; Troester MA; Hilsenbeck SG; Medina D; Perou CM; Rosen JM
    Proc Natl Acad Sci U S A; 2012 Feb; 109(8):2778-83. PubMed ID: 21633010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metalloprotease-disintegrin ADAM12 actively promotes the stem cell-like phenotype in claudin-low breast cancer.
    Duhachek-Muggy S; Qi Y; Wise R; Alyahya L; Li H; Hodge J; Zolkiewska A
    Mol Cancer; 2017 Feb; 16(1):32. PubMed ID: 28148288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EMT inducers catalyze malignant transformation of mammary epithelial cells and drive tumorigenesis towards claudin-low tumors in transgenic mice.
    Morel AP; Hinkal GW; Thomas C; Fauvet F; Courtois-Cox S; Wierinckx A; Devouassoux-Shisheboran M; Treilleux I; Tissier A; Gras B; Pourchet J; Puisieux I; Browne GJ; Spicer DB; Lachuer J; Ansieau S; Puisieux A
    PLoS Genet; 2012; 8(5):e1002723. PubMed ID: 22654675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGFβ induces the formation of tumour-initiating cells in claudinlow breast cancer.
    Bruna A; Greenwood W; Le Quesne J; Teschendorff A; Miranda-Saavedra D; Rueda OM; Sandoval JL; Vidakovic AT; Saadi A; Pharoah P; Stingl J; Caldas C
    Nat Commun; 2012; 3():1055. PubMed ID: 22968701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers.
    Lim E; Vaillant F; Wu D; Forrest NC; Pal B; Hart AH; Asselin-Labat ML; Gyorki DE; Ward T; Partanen A; Feleppa F; Huschtscha LI; Thorne HJ; ; Fox SB; Yan M; French JD; Brown MA; Smyth GK; Visvader JE; Lindeman GJ
    Nat Med; 2009 Aug; 15(8):907-13. PubMed ID: 19648928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of tumor-initiating cells by exogenous delivery of OCT4 transcription factor.
    Beltran AS; Rivenbark AG; Richardson BT; Yuan X; Quian H; Hunt JP; Zimmerman E; Graves LM; Blancafort P
    Breast Cancer Res; 2011 Sep; 13(5):R94. PubMed ID: 21952072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.